Cam Mingay and Rowan Groenewald have co-authored an article for New Cannabis Ventures: “Why and How U.S. Cannabis Companies Should Consider Going Public in Canada.”
The article takes a look at the advantages of – and provides advice on how – U.S. cannabis companies can go public in Canada.
Topics in the article include the benefits of going public in Canada, the use of reverse takeovers (RTOs) and initial public offerings (IPOs), and the investor’s perspective.